Molecular epidemiology of co‐infection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare, Zimbabwe
The objective of this study was to determine the prevalence of co-infection with hepatitis B virus (HBV) and human immunodeficiency virus (HIV) and the genetic characteristics of both viruses among pre-HIV-treatment patients in Harare, Zimbabwe. This cross-sectional survey involved 176 remnant plasma samples collected from consenting HIV patients (median age 35 [18-74]) between June and September 2014. HBV seromarkers were determined by high-sensitivity chemiluminescence assays. Molecular evolutionary analyses were conducted on the basal core promoter/precore (BCP/PC) and S regions of HBV, as well as part of the HIV pol region. Of the 176 participants (65.7% female), 19 (10.8%) were positive for HBsAg (median 0.033IU/ml (IQR 0.01-415). The HBsAg incidence was higher in men than women (P=0.009). HBsAg-positive subjects had lower median CD4 counts (P=0.016). HBV DNA was detectable in 12 HBsAg-positive samples (median 3.36 log cp/ml (2.86-4.51), seven being amplified and sequenced. All isolates were subgenotype A1 without HBV drug resistance mutations but each had at least one BCP/PC mutation. PreS deletion mutants and small S antigen variants M133I/T and D144G were identified. Of the 164 HIV isolates successfully genotyped, 163 (99.4%) were HIV-1 subtype C and only one was HIV-1 subtype F1. Sixteen (9.8%) had at least one drug resistance mutation, predominantly non-nucleoside reverse transcriptase inhibitor-related mutations, observed mostly among female participants. This study shows that co-infection with HBV is present among HIV patients enrolling into HIV care in Zimbabwe, suggesting that HBV screening and monitoring programmes be strengthened in this context. J. Med. Virol. 89:257-266, 2017. © 2016 Wiley Periodicals, Inc..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:89 |
|---|---|
| Enthalten in: |
Journal of medical virology - 89(2017), 2, Seite 257-266 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Baudi, Ian [VerfasserIn] |
|---|
| Links: |
|---|
| BKL: | |
|---|---|
| Themen: |
Epidemiology |
| RVK: |
|---|
| doi: |
10.1002/jmv.24641 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1990261744 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1990261744 | ||
| 003 | DE-627 | ||
| 005 | 20230507231647.0 | ||
| 007 | tu | ||
| 008 | 170303s2017 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1002/jmv.24641 |2 doi | |
| 028 | 5 | 2 | |a PQ20170301 |
| 035 | |a (DE-627)OLC1990261744 | ||
| 035 | |a (DE-599)GBVOLC1990261744 | ||
| 035 | |a (PRQ)p1571-9bbdf2c4ae6694445afe2bac08f613e098205dbdf8a70599d397bbbc279ceea53 | ||
| 035 | |a (KEY)0015763520170000089000200257molecularepidemiologyofcoinfectionwithhepatitisbvi | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 084 | |a XA 10000 |q AVZ |2 rvk | ||
| 084 | |a 44.00 |2 bkl | ||
| 100 | 1 | |a Baudi, Ian |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Molecular epidemiology of co‐infection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare, Zimbabwe |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a The objective of this study was to determine the prevalence of co-infection with hepatitis B virus (HBV) and human immunodeficiency virus (HIV) and the genetic characteristics of both viruses among pre-HIV-treatment patients in Harare, Zimbabwe. This cross-sectional survey involved 176 remnant plasma samples collected from consenting HIV patients (median age 35 [18-74]) between June and September 2014. HBV seromarkers were determined by high-sensitivity chemiluminescence assays. Molecular evolutionary analyses were conducted on the basal core promoter/precore (BCP/PC) and S regions of HBV, as well as part of the HIV pol region. Of the 176 participants (65.7% female), 19 (10.8%) were positive for HBsAg (median 0.033IU/ml (IQR 0.01-415). The HBsAg incidence was higher in men than women (P=0.009). HBsAg-positive subjects had lower median CD4 counts (P=0.016). HBV DNA was detectable in 12 HBsAg-positive samples (median 3.36 log cp/ml (2.86-4.51), seven being amplified and sequenced. All isolates were subgenotype A1 without HBV drug resistance mutations but each had at least one BCP/PC mutation. PreS deletion mutants and small S antigen variants M133I/T and D144G were identified. Of the 164 HIV isolates successfully genotyped, 163 (99.4%) were HIV-1 subtype C and only one was HIV-1 subtype F1. Sixteen (9.8%) had at least one drug resistance mutation, predominantly non-nucleoside reverse transcriptase inhibitor-related mutations, observed mostly among female participants. This study shows that co-infection with HBV is present among HIV patients enrolling into HIV care in Zimbabwe, suggesting that HBV screening and monitoring programmes be strengthened in this context. J. Med. Virol. 89:257-266, 2017. © 2016 Wiley Periodicals, Inc. | ||
| 540 | |a Nutzungsrecht: © 2016 Wiley Periodicals, Inc. | ||
| 650 | 4 | |a mutation/mutation rate | |
| 650 | 4 | |a hepatitis B virus | |
| 650 | 4 | |a virus classification | |
| 650 | 4 | |a evolution | |
| 650 | 4 | |a human immunodeficiency virus | |
| 650 | 4 | |a Epidemiology | |
| 650 | 4 | |a Human immunodeficiency virus--HIV | |
| 650 | 4 | |a Hepatitis | |
| 700 | 1 | |a Iijima, Sayuki |4 oth | |
| 700 | 1 | |a Chin'ombe, Nyasha |4 oth | |
| 700 | 1 | |a Mtapuri‐Zinyowera, Sekesai |4 oth | |
| 700 | 1 | |a Murakami, Shuko |4 oth | |
| 700 | 1 | |a Isogawa, Masanori |4 oth | |
| 700 | 1 | |a Hachiya, Atsuko |4 oth | |
| 700 | 1 | |a Iwatani, Yasumasa |4 oth | |
| 700 | 1 | |a Tanaka, Yasuhito |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of medical virology |d Hoboken, NJ : Wiley-Liss, 1977 |g 89(2017), 2, Seite 257-266 |w (DE-627)130482439 |w (DE-600)752392-0 |w (DE-576)016070275 |x 0146-6615 |7 nnns |
| 773 | 1 | 8 | |g volume:89 |g year:2017 |g number:2 |g pages:257-266 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1002/jmv.24641 |3 Volltext |
| 856 | 4 | 2 | |u http://onlinelibrary.wiley.com/doi/10.1002/jmv.24641/abstract |
| 856 | 4 | 2 | |u http://search.proquest.com/docview/1845027930 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_4012 | ||
| 936 | r | v | |a XA 10000 |
| 936 | b | k | |a 44.00 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 89 |j 2017 |e 2 |h 257-266 | ||